Association of toll-like receptor 3 polymorphisms with chronic hepatitis b and hepatitis B-related acute-on-chronic liver failure

Inflammation

Volumn 36, Issue 2, 2013, Pages 413-418

  Rong, Yihui ^a,b   Song, Haihan ^c   You, Shaoli ^b   Zhu, Bing ^b   Zang, Hong ^b   Zhao, Yi ^d   Li, Yongli ^b   Wan, Zhihong ^b   Liu, Hongling ^b   Zhang, Aimin ^b   Xiao, Long ^b   Xin, Shaojie ^b  

^a MEDICAL SCHOOL OF CHINESE PLA   (China)

^b BEIJING 302 HOSPITAL   (China)

^c UNIVERSITY OF TORONTO   (Canada)

^d Liver Diseases Center   (China)

Author keywords

acute on chronic liver failure; chronic hepatitis B; polymorphism; toll like receptor 3

Indexed keywords

ALANINE; CYSTEINE; THREONINE; TOLL LIKE RECEPTOR 3;

ACUTE ON CHRONIC LIVER FAILURE; ADULT; AGE DISTRIBUTION; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS B; HETEROZYGOTE; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PROGNOSIS; RECEPTOR GENE; RISK ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 3 GENE;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; END STAGE LIVER DISEASE; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER FAILURE, ACUTE; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TOLL-LIKE RECEPTOR 3;

HEPATITIS B VIRUS;

EID: 84879315454     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-012-9560-4     Document Type: Article

References (22)

1. Tan, Y.J. 2011. Hepatitis B virus infection and the risk of hepatocellular carcinoma. World Journal of Gastroenterology 17: 4853-4857.
2. Gish, R.; J.D. Jia, S. Locarnini, and F. Zoulim. 2012. Selection of chronic hepatitis B therapy with high barrier to resistance. The Lancet Infectious Diseases 12: 341-353.
3. Olson, J.C.; and P.S. Kamath. 2012. Acute-on-chronic liver failure: What are the implications? Current Gastroenterology Reports 14: 63-66.
4. Lee, C.C.; A.M. Avalos, and H.L. Ploegh. 2012. Accessory molecules for Toll-like receptors and their function. Nature Reviews Immunology 12: 168-179.
5. Horscroft, N.J.; D.C. Pryde, and H. Bright. 2012. Antiviral applications of Toll-like receptor agonists. The Journal of Antimicrobial Chemotherapy 67: 789-7801.
6. Hornung, V.; S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdorfer, T. Giese, et al. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of Immunology 168: 4531-4537.
7. Schwarz, K.; T. Storni, V. Manolova, A. Didierlaurent, J.C. Sirard, P. Rothlisberger, et al. 2003. Role of Toll-like receptors in costimulating cytotoxic T cell responses. European Journal of Immunology 33: 1465-1470.
8. Kaisho, T.; and S. Akira. 2003. Regulation of dendritic cell function through Toll-like receptors. Current Molecular Medicine 3: 373-385.
9. Bsibsi, M.; R. Ravid, D. Gveric, and J.M. van Noort. 2002. Broad expression of Toll-like receptors in the human central nervous system. Journal of Neuropathology and Experimental Neurology 61: 1013-1021.
10. Zhou, Y.; X. Wang, M. Liu, Q. Hu, L. Song, L. Ye, D. Zhou, and W. Ho. 2010. A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages. Immunology 131: 40-49.
11. Li, N.; Q. Li, Z. Qian, Y. Zhang, M. Chen, and G. Shi. 2009. Impaired TLR3/IFN-beta signaling in monocyte-derived dendritic cells from patients with acute-on-chronic hepatitis B liver failure: Relevance to the severity of liver damage. Biochemical and Biophysical Research Communications 390: 630-635.
12. Ueta, M.; C. Sotozono, T. Inatomi, K. Kojima, K. Tashiro, et al. 2007. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome. The British Journal of Ophthalmology 91: 962-965.
13. Sironi, M.; M. Biasin, R. Cagliani, D. Forni, M. De Luca, I. Saulle, et al. 2012. A common polymorphism in TLR3 confers natural resistance to HIV-1 infection. Journal of Immunology 188: 818-823.
14. Mandal, R.K.; G.P. George, and R.D. Mittal. 2012. Association of Toll-like receptor (TLR) 2, 3 and 9 genes polymorphism with prostate cancer risk in North Indian population. Molecular Biology Reports 39: 7263-7269.
15. Dai, J.; Z. Hu, J. Dong, L. Xu, S. Pan, Y. Jiang, et al. 2012. Host immune gene polymorphisms were associated with the prognosis of non-small-cell lung cancer in Chinese. International Journal of Cancer 130: 671-676.
16. Breckpot, K.; D. Escors, F. Arce, L. Lopes, K. Karwacz, et al. 2010. HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. Journal of Virology 84: 5627-5636.
17. Daffis, S.; M.A. Samuel, M.S. Suthar, M. Gale Jr.; and M.S. Diamond. 2008. Toll-like receptor 3 has a protective role against West Nile virus infection. Journal of Virology 82: 10349-10358.
18. Klein Klouwenberg, P.; L. Tan, W. Werkman, G.M. van Bleek, and F. Coenjaerts. 2009. The role of Toll-like receptors in regulating the immune response against respiratory syncytial virus. Critical Reviews in Immunology 29: 531-550.
19. Li, K.; N.L. Li, D. Wei, S.R. Pfeffer, M. Fan, and L.M. Pfeffer. 2012. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates. Hepatology 55: 666-6675.
20. Wu, J.; M. Lu, Z. Meng, M. Trippler, R. Broering, A. Szczeponek, et al. 2007. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 46: 1769-1778.
21. Wang, K.; H. Liu, Y. He, T. Chen, Y. Yang, et al. 2010. Correlation of TLR1-10 expression in peripheral blood mononuclear cells with chronic hepatitis B and chronic hepatitis B-related liver failure. Human Immunology 71: 950-956.
22. Ranjith-Kumar, C.T.; W. Miller, J. Sun, J. Xiong, J. Santos, I. Yarbrough, et al. 2007. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. The Journal of Biological Chemistry 282: 17696-17705.